The development and hosting of this resource hub has been sponsored by GSK. This resource hub contains links to clinical resources, some of which may be promotional in nature.

Delivering excellence in asthma management

Dr Neil Martin, Medical Expert Lead at GSK, highlights the importance of good asthma management by discussing the National Review of Asthma Deaths (NRAD) and the Asthma UK prescribing report.

Adverse Events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

Relvar Ellipta (fluticasone furoate/vilanterol) prescribing information

UK/RESP/0476/18a
Trademarks are owned by or licensed to the GSK group of companies.
Date of preparation: February 2019.

Respiratory resource hub